ZTSZoetis Inc.

ZTS Stock Price, Valuation & Chart | Zoetis Inc.

$77.220+0.12 (+0.16%)

At close · 01 Sept 2026, 07:59 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic ZTS intrinsic value ZTS calculated fair value vs price

Overview Financials Dividends Ratios

ZTS Historical price chart

ZTS Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization32.37B

PE Ratio11.74

EPS6.58

Trading Volume3.79M

Today's High/Low77.91/76.18

Dividend Yield2.71

52 Week High/Low155.38/71.0

Shares Outstanding419.23M

ZTS Financial Statement

ZTS Analyst ratings

ZTS Analysis & performance metrics

ZTS Company profile

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It…

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which…

ZTS Management team

Name

Position

Robert J. Polzer Ph.D.

Executive Vice President and President of Research & Development

Steven Frank

Vice President of Investor Relations

Julie A. Fuller

Executive Vice President, Chief Human Resources Officer & Global Operations

Nick Ashton

Executive Vice President and President of Global Manufacturing & Supply

Keith Sarbaugh

Executive Vice President & Chief Digital and Technology Officer

Wetteny N. Joseph CPACFO

Executive Vice President & Chief Financial Officer

Roxanne Lagano

Executive Vice President, General Counsel & Corporate Secretary

Jamie Brannan

Executive Vice President & Chief Commercial Officer

Name

Position

Robert J. Polzer Ph.D.

Executive Vice President and President of Research & Development

Steven Frank

Vice President of Investor Relations

Julie A. Fuller

Executive Vice President, Chief Human Resources Officer & Global Operations

Nick Ashton

Executive Vice President and President of Global Manufacturing & Supply

Keith Sarbaugh

Executive Vice President & Chief Digital and Technology Officer

Wetteny N. Joseph CPACFO

Executive Vice President & Chief Financial Officer

Roxanne Lagano

Executive Vice President, General Counsel & Corporate Secretary

Jamie Brannan

Executive Vice President & Chief Commercial Officer

Management Team

Robert J. Polzer Ph.D.

Executive Vice President and President of Research & Development

Steven Frank

Vice President of Investor Relations

Julie A. Fuller

Executive Vice President, Chief Human Resources Officer & Global Operations

Nick Ashton

Executive Vice President and President of Global Manufacturing & Supply

Keith Sarbaugh

Executive Vice President & Chief Digital and Technology Officer

Wetteny N. Joseph CPACFO

Executive Vice President & Chief Financial Officer

Roxanne Lagano

Executive Vice President, General Counsel & Corporate Secretary

Jamie Brannan

Executive Vice President & Chief Commercial Officer

Management

Robert J. Polzer Ph.D.

Executive Vice President and President of Research & Development

Steven Frank

Vice President of Investor Relations

Julie A. Fuller

Executive Vice President, Chief Human Resources Officer & Global Operations

Nick Ashton

Executive Vice President and President of Global Manufacturing & Supply

Keith Sarbaugh

Executive Vice President & Chief Digital and Technology Officer

Wetteny N. Joseph CPACFO

Executive Vice President & Chief Financial Officer

Roxanne Lagano

Executive Vice President, General Counsel & Corporate Secretary

Jamie Brannan

Executive Vice President & Chief Commercial Officer

Total 8 executives

ZTS Frequently asked questions

What is Zoetis Inc. (ZTS) Stock Price?

Current stock price of Zoetis Inc. (ZTS) stock is $77.220. The stock price is +0.16% higher in the session. The intraday range can be seen from this page. Volume of Zoetis Inc. (ZTS) stock is 3.79M.

Last updated at 01 Sept 2026, 07:59 pm.

Why is the Zoetis Inc. (ZTS) stock price going up or down today?

The stock price of Zoetis Inc. (ZTS) can change with earnings, company news, and overall market sentiment. Zoetis Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Zoetis Inc. stock expensive at its current price?

Whether Zoetis Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ZTS on this page is 11.74. EPS on this page is 6.58. Compare those figures with peers and growth expectations before deciding if the current Zoetis Inc. price is justified.

How has the stock price of Zoetis Inc. (ZTS) performed historically?

Historical performance for Zoetis Inc. (ZTS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ZTS reacted to past earnings and market events.

Should I buy Zoetis Inc. (ZTS) stock, at this price?

Buying Zoetis Inc. (ZTS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.